New Hampshire Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$749K Buy
9,579
+1,738
+22% +$140K 0.14% 97
2026
Q1
$679K Buy
7,841
+453
+6% +$43.4K 0.14% 97
2025
Q4
$710K Sell
7,388
-709
-9% -$68.9K 0.14% 97
2025
Q3
$771K Buy
8,097
+1,101
+16% +$101K 0.15% 94
2025
Q2
$610K Buy
6,996
+544
+8% +$46.1K 0.13% 99
2025
Q1
$580K Buy
6,452
+837
+15% +$74.9K 0.13% 101
2024
Q4
$449K Sell
5,615
-167
-3% -$14.5K 0.09% 120
2024
Q3
$521K Buy
5,782
+55
+1% +$4.63K 0.11% 114
2024
Q2
$451K Sell
5,727
-72
-1% -$5.9K 0.1% 118
2024
Q1
$505K Buy
5,799
+448
+8% +$38.2K 0.12% 112
2023
Q4
$441K Sell
5,351
-1,162
-18% -$88.6K 0.11% 117
2023
Q3
$510K Sell
6,513
-118
-2% -$9.88K 0.14% 104
2023
Q2
$584K Sell
6,631
-1,189
-15% -$102K 0.15% 97
2023
Q1
$630K Sell
7,820
-795
-9% -$64.8K 0.17% 97
2022
Q4
$670K Buy
+8,615
New +$698K 0.18% 97

Other funds holding MDT

New Hampshire Trust's MDT Position: Q2 2026 in Review

New Hampshire Trust increased its Medtronic (MDT) stake by 22% in Q2 2026, buying an estimated $140K and bringing the position to 9,579 shares worth $749K. The position accounts for 0.14% of the portfolio, ranked #97.

New Hampshire Trust first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $771K in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • New Hampshire Trust held 9,579 shares of Medtronic worth $749K as of Q2 2026.
  • New Hampshire Trust bought 1,738 Medtronic shares in Q2 2026, an estimated $140K.
  • Medtronic made up 0.14% of New Hampshire Trust's portfolio in Q2 2026, its #97 holding.
  • New Hampshire Trust first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • New Hampshire Trust's Medtronic position peaked at $771K in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.